“The future is psychedelic,” declared Rick Doblin, founding father of Lykos Therapeutics, at a convention on psychedelic medication final yr. A number of research, a lot of them funded by Lykos, had supplied tantalising indicators that pairing MDMA with discuss remedy might dramatically cut back signs of post-traumatic stress dysfunction (PTSD). In consequence, Doblin was considered one of many advocates touting the drug as key to revolutionising psychological healthcare.
However only a yr later,…